Nanobody-Enhanced Targeting of AAV Gene Therapy Vectors-Reference-Cited by-同舟云学术

Nanobody-Enhanced Targeting of AAV Gene Therapy Vectors

Published:2019-12 Issue: Volume:15 Page:211-220
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Eichhoff Anna Marei,Börner Kathleen,Albrecht Birte,Schäfer Waldemar,Baum Natalie,Haag Friedrich,Körbelin Jakob,Trepel Martin,Braren Ingke,Grimm Dirk,Adriouch Sahil,Koch-Nolte Friedrich

Funder

Claussen-Simon-Stiftung

Deutsche Forschungsgemeinschaft

German Center for Infection Research

Agence Nationale de la Recherche

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference55 articles.

1. Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges;Mingozzi;Nat. Rev. Genet.,2011

2. Engineering adeno-associated viruses for clinical gene therapy;Kotterman;Nat. Rev. Genet.,2014

3. Emerging issues in AAV-mediated in vivo gene therapy;Colella;Mol. Ther. Methods Clin. Dev.,2017

4. Vectored immunoprophylaxis protects humanized mice from mucosal HIV transmission;Balazs;Nat. Med.,2014

5. Recombinant AAV as a platform for translating the therapeutic potential of RNA interference;Borel;Mol. Ther.,2014

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical strategies with antibody–drug conjugates as potential modifications for virotherapy;Drug Discovery Today;2024-09

2. Nano-Bio Interfaces: Pioneering Targeted Approaches for Disease Treatment and Prevention;Journal of Macromolecular Science, Part B;2024-08-28

3. Protein Carrier AAV;2024-08-14

4. T-cell specific in vivo gene delivery with DART-AAVs targeted to CD8;Molecular Therapy;2024-08

5. A facile chemical strategy to synthesize precise AAV-protein conjugates for targeted gene delivery;2024-07-20